Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas, Avenida Constantino Nery, 4397, 69050-001, Chapada, Manaus, Amazonas, Brazil; Laboratório de Imunoquímica, Departamento de Parasitologia, Instituto de Ciências Biológicas, Universidade Federal do Amazonas, Avenida Rodrigo Octávio Jordão Ramos, 6200, CEP 69077-000, Coroado II, Manaus, Amazonas, Brazil.
Programa de Pós-graduação em Recursos Naturais da Amazônia, Universidade Federal do Oeste do Pará, Avenida Mendonça Furtado, 2949, CEP 68040-470, Santarém, Pará, Brazil.
Toxicon. 2020 Oct 30;186:126-140. doi: 10.1016/j.toxicon.2020.08.006. Epub 2020 Aug 15.
Freshwater stingrays are cartilaginous fish with stingers at the base of their tail. The stinger is covered with an epithelium containing mucous and venom glands. Human envenomation usually occurs when a person steps on a stingray hiding in the sand and the fish sinks its stinger into the victim, causing an extremely painful wound which generally leads to tissue necrosis. Medical treatment is based on the use of painkillers, anti-inflammatory drugs and antibiotics, as there is to date no specific antidote for envenomation by freshwater stingrays. The aim of this study was therefore to investigate whether sera containing anti-P. motoro antibodies can neutralize the edema-forming and myotoxic activities of Potamotrygon motoro venom. To this end, two protocols were used: seroneutralization and vaccination of mice. The seroneutralization protocol involved intramuscular injection of the P. motoro venom in the mice gastrocnemius followed by administration of hyperimmune mouse serum anti P. motoro dorsal extract and stinger extract via the ophthalmic venous plexus. The vaccination protocol involved immunizing the mice with dorsal or stinger extract adsorbed to aluminum hydroxide followed by intramuscular challenge with the P. motoro venom. The gastrocnemii of all the animals were removed for histopathological and stereological analyses, and blood was collected via the ophthalmic venous plexus to measure IL-2, IL-4, IL-6, IL-10, IL-17A, IFN-γ, TNF, C-reactive protein and total creatine kinase. Protocols did not neutralize the edema-forming or local myotoxic induced by P. motoro venom under the experimental conditions tested. But systemic rhabdomyolysis was only completely neutralized in animals vaccinated with the stinger extract. Cytokine analysis revealed that under the experimental conditions used here, seroneutralization induced release of Th1, Th2, Th17 and Treg cytokines whereas vaccination induced a Th1 response.
淡水魟鱼是一种软骨鱼类,其尾部有刺。刺的表面覆盖着一层上皮组织,其中包含黏液腺和毒腺。当人踩到隐藏在沙子中的魟鱼时,鱼会将刺插入受害者体内,导致极其疼痛的伤口,通常会导致组织坏死,从而导致人类被刺。在这种情况下,医疗通常基于使用止痛药、消炎药和抗生素,因为到目前为止,淡水魟鱼毒液还没有特定的解毒剂。因此,这项研究的目的是研究含有抗-P.motoro 抗体的血清是否可以中和 Potamotrygon motoro 毒液的致水肿和肌毒性活性。为此,使用了两种方案:血清中和和小鼠疫苗接种。血清中和方案涉及将 P.motoro 毒液肌肉内注射到小鼠的腓肠肌中,然后通过眼静脉丛给予抗 P.motoro 背侧提取物和刺提取物的高免疫鼠血清。疫苗接种方案涉及用吸附在氢氧化铝上的背侧或刺提取物免疫小鼠,然后用 P.motoro 毒液进行肌肉内挑战。所有动物的腓肠肌均被切除,用于组织病理学和立体学分析,并通过眼静脉丛采集血液,以测量 IL-2、IL-4、IL-6、IL-10、IL-17A、IFN-γ、TNF、C-反应蛋白和总肌酸激酶。在实验条件下,方案没有中和 P.motoro 毒液引起的水肿形成或局部肌毒性。但是,仅在用刺提取物免疫接种的动物中完全中和了全身性横纹肌溶解症。细胞因子分析表明,在本实验条件下,血清中和诱导了 Th1、Th2、Th17 和 Treg 细胞因子的释放,而疫苗接种则诱导了 Th1 反应。